The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Lacrimal & Tear Fluid Yield Clues to Dry Eye Disease

Lacrimal & Tear Fluid Yield Clues to Dry Eye Disease

December 4, 2017 • By Lara C. Pullen, PhD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

New research suggests novel markers of dry eye disease can be found in the lacrimal fluid and tear fluid of patients. Jae Hun Jung, PhD, of Yonsei University College of Medicine in South Korea, and colleagues used in-depth proteomic analysis to compare tear fluid and lacrimal fluid proteins from patients with dry eye disease and healthy controls. They published their results online Oct. 17 in Scientific Reports. Their research focused on protein levels and did not compare expression patterns at the gene level in different tissues.1

You Might Also Like
  • New Options for Patients with Concurrent Dry Eye & Rheumatic Disease
  • Gut Microbes Activate T Cells Causing Autoimmune Eye Disease
  • Innate Immune Response Enters Center Stage for Inflammatory Eye Disease
Also By This Author
  • Exercise Therapy May Take the ‘Tired’ Out of Chronic Fatigue Syndrome

The investigators began their study by pooling tear fluid (n=5) and lacrimal fluid (n=5) samples from patients and comparing them with a similar pooling of samples from controls. They analyzed the proteins in the samples by liquid chromatography MS (LC-MS/MS) and found that approximately half of the detected proteins were common between tear fluid and lacrimal fluid. When the investigators looked more closely at the non-shared proteins, they identified 16 marker proteins of dry eye disease, three of which were upregulated in tear fluid, eight of which were upregulated in lacrimal fluid and five of which were down regulated in lacrimal fluid.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The researchers then performed Gene Ontology–Biological Processes (GO-BP) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses to specifically look at the cellular components of tear fluid and lacrimal fluid proteins. They found the cellular pool of tear fluid proteins comprised mostly extracellular region proteins, whereas the cellular pool of lacrimal fluid proteins comprised largely cytosol proteins. Additionally, the GO-BP category of immune/inflammatory response process was actively changed in lacrimal fluid, but not in tear fluid. More specifically, the most upregulated proteins in the lacrimal fluid belonged to the GO-BP category of immune response.

“In this study, we identified a larger number of proteins in [lacrimal fluid] than in [tear fluid] (1,448 vs. 1,165), although [tear fluid] contains a greater number of different cells, such as the corneal epithelium, immune cells, nerves, vascular cells, Goblet cells and Meibomian gland cells,” write the authors in their discussion. “Moreover, approximately half of the identified proteins (849) were common between [tear fluid] and [lacrimal fluid]. These results indicate that 316 [tear fluid] proteins were not secreted from the [lacrimal gland ] and that the [lacrimal gland] contributes approximately three-quarters of the [tear fluid] protein composition.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The team then sought to verify the candidate biomarkers via the highly sensitive and selective multiple reaction monitoring assay. They isolated and identified nearly 1,700 proteins from ocular surface fluid from tear fluid and lacrimal fluid of 17 patients with dry eye disease and 17 healthy controls. Closer analysis revealed 138 differentially expressed proteins in tear fluid and 161 differentially expressed proteins in lacrimal fluid. Their research suggests that immune response-related proteins in the complement pathway are upregulated at the protein level in the lacrimal fluid of patients with dry eye disease and may be an important marker of disease.

Pages: 1 2 | Single Page

Filed Under: Conditions, Systemic Inflammatory Syndromes Tagged With: Dry eye, eye, Eye disease, tear fluid

You Might Also Like:
  • New Options for Patients with Concurrent Dry Eye & Rheumatic Disease
  • Gut Microbes Activate T Cells Causing Autoimmune Eye Disease
  • Innate Immune Response Enters Center Stage for Inflammatory Eye Disease
  • Optical Workings: Specialists Must Communicate to Treat Eye Disease

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)